Objective:To test the hypothesis that multiple courses of antenatal corticosteroids accentuate the decreases in blood-brain barrier permeability observed after a single course of corticosteroids in pretern ovine fetuses.
Methods:Chronically instrumented 106-day gestation ovine fetuses were studied after single and multiple courses of dexamethasone or placebo were given to ewes beginning at 104 to 106 or 76 to 78 days of gestation, respectively. In the single-course groups, the ewes received dexamethasone (6 mg, n = 6) or placebo (n = 6) as four intramuscular injections every 12 hours over 48 hours. In the multiple course groups, the ewes received the same treatment (dexamethasone, n = 9, or placebo, n = 8), once per week for 5 weeks starting at 76 to 78 days of gestation. Blood-brain barrier permeability was quantified with the blood-to-brain transfer constant (Ki) for α-aminoisobytyric acid (AIB) in the brain regions of the fetuses 12 hours after the last injection of dexamethasone was given to the ewes at 106 to 107 days of gestation.
Results:Both single (analysis of variance [ANOVA]; main effects for dexamethasone treatment, F = 5.92, P <.04) and multiple (ANOVA; main effects for dexamethasone treatment, F = 4.74, P <.04) course of antenatal corticosteriods were associated with decreases in blood-brain barrier permeability in the brain regions of the ovine fetus. However, the multiple course did not accentuate (ANOVA; main effects for single versus multiple courses, F = 1.06, P = .32) the decreases in permeability observed after a single course.
Conclusion:Contrary to our hypothesis, antenatal treatment with a 5-week course of corticosteroids did not accentuate the reductions in blood-brain barrier permeability that we observed after a single course of corticosteroids in the fetus.
1. Newnham JP, Moss TJ, Nitsos I, Sloboda DM. Antenatal corticosteroids: the good, the bad and the unknwon. Curr Opin Obstet Gynecol2002;14:607-612.
2.
2. Rajadurai VS, Tan KH. The use and abuse of steroids in perinatal medicine. Ann Acad Med Singapore2003;32:324-334.
3.
3. Vidaeff AC, Mastrobatista JM. Controversies in the use of antenatal steroids for fetal maturation. Semin Perinatol2001;25:385-396.
4.
4. Berry LM, Polk DH, Ikegami M, Jobe AH, Padbury JF, Ervin MG. Pretern newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethsaone. Am J Physiol1997;272:R1972-R1979.
5.
5. Okah FA, Pickens WL, Hoath SB. Effect of prenatal steroids on skin surface hydrophobicity in the premature rat. Pediatr Res1995;37:402-408.
6.
6. Stonestreet BS, Hansen NB, Laptook AR, Oh W. Glucocorticoid accelerates renal functional maturation in fetal lambs. Early Hum Dev1983;8:331-341.
7.
7. Stonestreet BS, Petersson KH, Sadowska GB, Pettigrew KD, Patlak CS. Antenatal steroids decrease blood-brain barrier permeability in the ovine fetus. Am J Physiol1999;276:R283-R289.
8.
8. Adams DF, Ment LR, Vohr B. Antenatal therapies and the developing brain. Semin Neonatol2001;6:173-183.
9.
9. Schwab M, Antonow-Schlorke I, Kuhn B, et al. Effect of antenatal betamethasone treatment on microtubule-associated proteins MAP1B and MAP2 in fetal sheep. J Physiol2001;530:497-506.
10.
10. Schwab M, Roedel M, Anwar MA, et al. Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow. J Physiol2000;528:619-632.
11.
11. Schwab M, Schmidt K, Roedel M, et al. Non-linear changes of elecrocortical activity after antenatal betamethasone treatment in fetal sheep. J Physiol2001;531:535-543.
12.
12. Stonestreet BS, Sadowska GB, McKnight AJ, Patlak C, Petersson KH. Exogenous and endogenous corticosteroids modulate blood-brain barrier development in the ovine fetus. Am J Physiol Regul Integr Comp Physiol2000;279:R468-R477.
13.
13. Guinn DA, Atkinson MW, Sullivan L, et al. Single vs weekly course of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA2001;286:1581-1587.
14.
14. Leung TN, Lam PM, Ng PC, Lau TK. Repeated courses of antenatal corticosteroids: Is it justified?Acta Obstet Gynecol Scand2003;82:589-596.
15.
15. Pratt L, Waschbusch L, Ladd W, Gangnon R, Hendricks SK. Multiple vs. Single betamethasone therapy. Neonatal and maternal effects . J Reprod Med1999;44:257-264.
16.
16. National Institutes of Health Consensus Development Panel. Antenatal corticosteroids revisited: Repeat courses. Bethesda, MD: U.S. Department of Health and Human Services. 2000;17:1-18.
17.
17. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol1999;180:114-121.
18.
18. Throp JA, Jones AM, Hunt C, Clark R. The effect of multidose antenatal betamethasone on maternal and infant outcomes. Am J Obstet Gynecol2001;184:196-202.
19.
19. Quinlivan JA, Evans SF, Dunlop SA, Beazley LD, Newnham JP. Use of corticosteroids by Australian obstetricians—A survey of clinical practice. Aust N Z J Obstet Gynaecol1998;38:1-7.
20.
20. Sloboda DM, Newnham JP, Challis JR. Effects of repeated maternal betamethasone administration on growth and hypothalamic-pituitary-adrenal function of the ovine fetus at term. J Endocrinol2000;165:79-91.
21.
21. Kutzler MA, Ruane EK, Coksaygan T, Vincent SE, Nathanielsz PW. Effects of three courses of maternally administered dexamethasone at 0.7, 0.75, and 0.8 of gestation on prenatal and postnatal growth in sheep. Pediatrics2004;113:313-319.
22.
22. Huang WL, Beazley LD, Quinlivan JA, Evans SF, Newnhan JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol1999;94:213-218.
23.
23. Stonestreet BS, Patlak CS, Pettigrew KD, Reily CB, Cserr HF. Ontogeny of blood-brain barrier function in ovine fetuses, lambs and adults. Am J Physiol1996;271:R1594-R1601.
24.
24. Kerzner LS. Stonestreet BS, Wu KY, Sadowska G, Malee MP. Antenatal dexamethasone: Effect on ovine placental 11 beta-hydroxysteroid dehydrogenase type 2 expression and fetal growth. Pediatr Res2002;52:706-712.
25.
25. Hai CM, Sadowska G, Francois L, Stonestreet BS. Maternal dexamethasone treatment alters myosin isoform expression and contractile dynamics in fetal arteries. Am J Physiol Heart Circ Physiol2002;283:H1743-H1749.
26.
26. Stonestreet BS, Watkins, S, Petersson KH, Sadowska GB. Effects of multiple courses of antenatal corticosteroids on regional brain and somatic tissue water content in ovine fetuses. J Soc Gynecol Investig2004;11:166-174.
27.
27. Derks JB, Giussani DA, Jenkins SL, et al. A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep. J Physiol1997;499:217-226.
28.
28. Blaberg RG, Fenstermacher JD, Patlak CS. Transport of alphaaminoisobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow Metab1983;3:8-32.
29.
29. Ohno K, Pettigrew KD, Rapoport SI. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol1978;235:H299-H307.
30.
30. Tuor U, Simone C, Bascaramurty S. Local blood-brain barrier in the newborn rabbit: Postnatal changes in α-aminosiobutyric acid transfer within medulla, cortex and selected brain areas. J Neurochem1992;59:999-1007.
31.
31. Cserr H, DePasuqale M, Patlak C. Volume regulatory influx of electrolytes from plasma to brain during acute hyperosmolality. Am J Physiol1987;253:F530-F537.
32.
32. Stonestreet BS, McKnight AJ, Sadowska G, Petersson KH, Oen JM, Patlak CS. Effect of duration of positive-pressure ventilation on blood-brin barrier function in premature lambs. J Appl Physiol2000;88:1672-1677.
33.
33. Sysyn GD, Petersson KH, Patlak CS, Sadowska GB, Stonestreet BS. Effects of postnatal dexamethasone on blood-brain barrier permeability and brain water content in newborn lambs. Am J Physiol Regular Integr Comp Physiol2001;280:R547-R553.
34.
34. Pardridge WM, Triguero D, Yang J, Cancilla PA. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J Pharmacol Exp Ther1990;253:884-891.
35.
35. Al-Yatama MK, Al Essa M, Omu AE, Al-Shamali I, Egbase P, Rashwan N. Effect of repeated doses of dexamethasone on the incidence and severity of distress syndrome in multifetal gestation between 24 and 34 weeks. Gynecol Obstet Invest2001;52:26-33.
36.
36. Ballabh P, Lo ES, Kumari J, et al. Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther2002;71:39-45.
37.
37. Turrentine MA, Ramirez MM. Adverse perinatal events and subsequent cesarean rate. Obstet Gynecol1999;94:185-188.
38.
38. National Institute of Health Consensus Conference. Effect of corticosteroirds for fetal maturation on perinatal outcomes. NH Consensus Development Panel on the Effect of Coricosteroids for fetal Maturation on Perinatal Outcomes. JAMA1995;273:413-418.
39.
39. Padbury JF, Polk DH, Ervin MG, Berry LM, Ikegami M, Jobe AH. Postnatal cardiovascular and metabolic responses to a single intramuscular dose of betamthasone in fetal sheep born prematurely by cesarean section. Pediatr Res1995;38:709-715.
40.
40. Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol1969;45:515-523.
41.
41. Huang WL, Harper CG, Evans SF, Newnham JP, Dunlop SA. Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int J Dev Neurosci2001;19:415-425.
42.
42. Schinkel AH, Wagenaar, E, van Deemter L, Mol CA, Borst P. Absence of the mdr1a P-gycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest1995;96:1698-1705.
43.
43. Yates CR, Chang C, Kearbey JD, et al. Structural determinants of P-glycoprotein-mediated transport of glucocorticoids. Pharm Res2003;20:1794-1803.
44.
44. Uhr M, Holsboer F, Muller MB. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol2002;14:753-759.
45.
45. Aghajafari F, Murphy K, Matthews S, Ohlsson A, Amankwah K, Hannah M. Repeated doses of antenatal corticosteroids in antimals: A systematic review. Am J Obstet Gynecol2002;186:843-849.
46.
46. Cotterrell M, Balazs R, Johnson AL. Effects of corticosteriods on the biochemical maturation of rat brain: Postnatal cell formation. J Neurochem1972;19:2151-2167.
47.
47. Huang WL, Harper CG, Evans SF, Newnham JP, Dunlop SA. Repeated prenatal corticosteriod administration delays astrocyte and capillary tight junction maturation in fetal sheep. Int J Dev Neurosci2001;19:487-493.
48.
48. Johnson JW, Mitzner W, Beck JC, et al. Long-term effects of betamethasone on fetal development. Am J Obstet Gynecol1981;141:1053-1064.
49.
49. Slotkin TA, Lappi SE, McCook EC, Tayyeb MI, Eylers JP, Seidler FJ. Glucocorticoids and the development of neuronal function: Effects of prenatal dexamethasone exposure on central noradrenergic activity. Biol Neonate1992;61:326-336.
50.
50. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res1990;53:157-167.
51.
51. Huang WL, Dunlop SA, Harper CG. Effect of exogenous corticosteroids on the developing central nervous system: A review. Obstet Gynecol Surv1999;54:336-342.
52.
52. Moss TJ, Doherty DA, Nitsos I, Sloboda DM, Harding R, Newnham JP. Effects into adulthood of single or repeated antenatal corticosteroids in sheep. Am J Obstet Gynecol2005;192:146-152.
53.
53. Garland JS, Buck R, Leviton A. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorhage in surfactant-treated preterm infants. J Pediatr1995;126:272-279.
54.
54. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Duncan CC, Makuch RW. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol1995;172:795-800.
55.
55. Hoheisel D, Nitz T, Franke H, et al. Hydrocortisone reinforces the blood-brain properties in a serum free cell culture system. Biochem Biophys Res Commun1998;247:312-315.
56.
56. Fanning AS, Anderson JM. Protein modules as organizers of membrane structure. Curr Opin Cell Biol1999;11:432-439.
